Camilla Pereira da Silva

Camilla Pereira da Silva

Auto-generated profile, based on publicly available information

Camilla Pereira da Silva

Department of Genetics, Institute of Biology Roberto Alcantara Gomes, State University of Rio de Janeiro, Rio de Janeiro, Brazil

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in Journal of the Neurological Sciences
Verified
Journal Article
Closed access
CSCamilla P. da Silva
Camilla P. da Silva
GAGabriella de Medeiros Abreu
Gabriella de Medeiros Abreu
PAPedro H. Cabello Acero
Pedro H. Cabello Acero
MCMário Campos
Mário Campos
JPJoão S. Pereira
João S. Pereira
MPMárcia M.G. Pimentel
Márcia M.G. Pimentel

1 December 2016 in Neuroscience Letters
Verified
Journal Article
Closed access
GAGabriella de Medeiros Abreu
Gabriella de Medeiros Abreu
DVDébora Cristina T. Valença
Débora Cristina T. Valença
MCMário Campos
Mário Campos
CSCamilla P. da Silva
Camilla P. da Silva
JPJoão S. Pereira
João S. Pereira
MPMárcia M.G. Pimentel
Márcia M.G. Pimentel

1 February 2019 in Neurobiology of Aging
Verified
Journal Article
Closed access
DVDanielle D. Voigt
Danielle D. Voigt
CNCaroline M. Nascimento
Caroline M. Nascimento
RSRitiele B. de Souza
Ritiele B. de Souza
PAPedro H. Cabello Acero
Pedro H. Cabello Acero
MJMário Campos Júnior
Mário Campos Júnior
MPMárcia M.G. Pimentel
Márcia M.G. Pimentel

24 November 2023 in Expert Review of Molecular Diagnostics
Verified
Journal Article
Closed access
CSCamilla Pereira da Silva
Camilla Pereira da Silva
DCDiego Camuzi
Diego Camuzi
ARAdriana Helena de Oliveira Reis
Adriana Helena de Oliveira Reis
AGAndressa Pereira Gonçalves
Andressa Pereira Gonçalves
JSJussara Mendonça dos Santos
Jussara Mendonça dos Santos
CRCíntia Rebouças
Cíntia Rebouças
BackgroundFragile X syndrome (FXS) is primarily due to CGG repeat expansions in the FMR1 gene. FMR1 alleles are classified as normal (N), intermediate (I), premutation (PM), and full mutation (FM). FXS patients often carry an FM, but size mosaicism can occur. Additionally, loss of methylation boundary upstream of repeats results in de novo methylation spreading to FMR1 promoter in FXS patients.Research design and methodsThis pilot study investigated the methylation boundary and adjacent regions in 66 males with typical and atypical FXS aged 1 to 30 years (10.86 +/- 6.48 years). AmplideX FMR1 mPCR kit was used to discriminate allele profiles and methylation levels. CpG sites were assessed by pyrosequencing.Results40 out of 66 FXS patients (60.6%) showed an exclusive FM (n = 40), whereas the remaining (n = 26) exhibited size mosaicism [10 PM_FM (15.15%); 10 N_FM (15.15%); 2 N_PM_FM (3%)]. Four patients (6.1%) had deletions near repeats. Noteworthy, a CpG within FMR1 intron 2 displayed hypomethylation in FXS patients and hypermethylation in controls, demonstrating remarkable specificity, sensitivity, and accuracy when a methylation threshold of 69.5% was applied.ConclusionsSince intragenic methylation is pivotal in gene regulation, the intronic CpG might be a novel epigenetic biomarker for FXS diagnosis.